News
In addition to Welch, Merkley, Sanders, and Dingell, the End Price Gouging for Medications Act is co-sponsored by U.S. Senator Dick Durbin (D-IL). The bicameral bill is endorsed by Public Citizen, ...
Taken together, the reports stand as an indictment of the entire programmatic ecosystem. Critics say the unsuitable ...
Representative Maria Elvira Salazar (R-FL) said she was "delighted" by President Donald Trump's executive order to lower ...
Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.
Buried in a technical document released by the Centers for Medicare and Medicaid Services is a convoluted paragraph that may ...
We are going to pay the lowest price there is in the world,” Trump said before signing the executive order, which was met with skepticism.
There are many problems with the plan. It ignores the fact, for instance, that generic drugs, which make up 90% of ...
The pharmaceutical industry, which is well known for its well-resourced lobbying campaigns, has a lesser-known tactic for influencing policy: bankrolling ostensibly independent nonprofit organizations ...
McDermott was pleased to once again host our annual European Health & Life Sciences Symposium in Paris. Welcoming a crowd of more than ...
President Trump could have walked softly and carried a big stick. As pharmaceutical investors see it, he instead stomped ...
The company had also said last month that Paul Stoffels, a pharma legend who took on the CEO role in 2022 in a bid to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results